Search results
Why CRISPR Therapeutics Stock Charged Northward This Week
Motley Fool· 7 months agoGene therapy stocks have been a bright spot in the market this week. For instance, gene correction...
The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 14, 2023 – Zacks.com announces the list of stocks...
Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?
Zacks via Yahoo Finance· 5 months agoIntellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company focused on developing...
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its...
Motley Fool via Yahoo Finance· 6 months agoDecember has been a big month for CRISPR Therapeutics (NASDAQ: CRSP). On Dec. 8, the Food and Drug...
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years
Motley Fool· 7 months agoThe pharmaceutical industry has been a source of extraordinary returns for investors who have picked...
The 3 Most Promising Gene Editing Stocks to Buy in 2023
InvestorPlace via Yahoo Finance· 1 year agoGene editing stocks are one of the hottest sectors in medicine today. Genes are the foundation of...
More Likely to 5X First: CRISPR Therapeutics vs. InMode
Motley Fool· 1 year agoOwning growth stocks in a bear market can be painful; fearful investors often flee to safety, and...
Here's Why You May Invest in CRISPR Therapeutics (CRSP) Stock
Zacks via Yahoo Finance· 8 months agoCRISPR Therapeutics AG CRSP is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make...
CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall?
Motley Fool via Yahoo Finance· 6 months agoOn Dec. 8, CRISPR Therapeutics (NASDAQ: CRSP) and its collaboration partner Vertex Pharmaceuticals...
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
InvestorPlace via Yahoo Finance· 6 months agoThe pharma stock leaders can at times seem overly risk averse with their approach to developing new...
